⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL66151 | 1.00 | — | — | |
| SCHEMBL74513 | 1.00 | — | — | |
| SCHEMBL66150 | 1.00 | — | — | |
| SCHEMBL9267031 | 1.00 | CHRNA7 (0.48) | — | |
| SCHEMBL21087936 | 1.00 | — | — | |
| SCHEMBL1039747 | 1.00 | — | — | |
| SCHEMBL1404039 | 0.97 | CHRNA7 (0.46) | — | |
| Hydrochloric Acid SCHEMBL731086 | 0.97 | CHRNA7 (0.46) | — | |
| SCHEMBL8712522 | 0.97 | CHRNA7 (0.46) | — | |
| Hydrochloric Acid SCHEMBL1191218 | 0.97 | CHRNA7 (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1057 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12358908-B2 | Crystals, preparation method and application of a muscarinic receptor antagonist | BEIJING SHOWBY PHARMACEUTICAL CO., LTD. (CN) | 2025-07-15 | — | — | US | claimed |
| CN-119324251-A | Polymer electrolyte, preparation method and application thereof | 蓝固(淄博)新能源科技有限公司 | 2025-01-17 | — | — | CN | claimed |
| US-20230167107-A1 | CRYSTALS, PREPARATION METHOD AND APPLICATION OF A MUSCARINIC RECEPTOR ANTAGONIST | BEIJING SHOWBY PHARMACEUTICAL CO., LTD. (CN) | 2023-06-01 | — | — | US | claimed |
| CN-114437060-B | Preparation method of (R) -and (S) -3-quinuclidinol | 凯特立斯（深圳）科技有限公司 | 2023-04-14 | — | — | CN | claimed |
| EP-4144733-A1 | CRYSTAL OF M RECEPTOR ANTAGONIST AS WELL AS PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | Beijing Showby Pharmaceutical Co., Ltd. (CN) | 2023-03-08 | — | — | EP | claimed |
| CN-112941041-B | Quininone reductase and application thereof in asymmetric synthesis of (R) -3-quininol | 江南大学 | 2023-02-10 | — | — | CN | claimed |
| CN-115397823-A | M receptor antagonist crystal, preparation method and application thereof | 北京硕佰医药科技有限责任公司 | 2022-11-25 | — | — | CN | claimed |
| CN-108203434-B | Asymmetric synthesis method for preparing solifenacin | 中国科学院上海药物研究所 | 2022-02-25 | — | — | CN | claimed |
| CN-112457307-B | Extraction method of R-quininol | 河北省科学院生物研究所 | 2022-02-01 | — | — | CN | claimed |
| CN-113200979-A | Synthesis process of solifenacin succinate | 上海予君生物科技发展有限公司 | 2021-08-03 | — | — | CN | claimed |
| EP-1757604-A1 | PROCESS FOR PRODUCING SOLIFENACIN OR ITS SALT | Astellas Pharma Inc. (JP) | 2007-02-28 | — | — | EP | claimed |
| EP-1726304-A1 | SOLIFENACIN-CONTAINING COMPOSITION | Astellas Pharma Inc. (JP) | 2006-11-29 | — | — | EP | claimed |
| EP-1714965-A1 | COMPOSITION CONTAINING SOLIFENACIN SUCCINATE | Astellas Pharma Inc. (JP) | 2006-10-25 | — | — | EP | claimed |
| US-20050227336-A1 | Methods for producing optically active alcohols | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2005-10-13 | — | — | US | claimed |
| US-20030143700-A1 | Methods for producing optically active alcohols | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2003-07-31 | — | — | US | claimed |
| EP-1318200-A2 | Methods for producing optically active alcohols | Daicel Chemical Industries, Ltd. (JP) | 2003-06-11 | — | — | EP | claimed |
| US-5888804-A | SIMPLE AND EFFICIENT BIOSYNTHESIS BY INCUBATING MICROORGANISM WITB QUINUCLIDINONE, RECOVERING OR HARVESTING PRODUCT | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1999-03-30 | — | — | US | claimed |
| EP-0863212-A2 | Processes for production of optical active quinuclidinol | Daicel Chemical Industries, Ltd. (JP) | 1998-09-09 | — | — | EP | claimed |
| EP-0577253-A2 | Enantiomeric enrichment of (R,S)-3-quinuclidinol | BEND RESEARCH, INC. (US) | 1994-01-05 | — | — | EP | claimed |
| US-5215918-A | Acid anhydride esterification; preferential enzymatic hydrolysis with a subtilisin protease | BEND RESEARCH, INC. (US) | 1993-06-01 | — | — | US | claimed |